ARA - 290 10mg

High-purity ARA-290 research peptide

Synthetic erythropoietin-derived peptide

Research focus on tissue repair pathways

Investigated in inflammation and neuropathy studies

Suitable for laboratory research applications

Manufactured to strict quality control standards

Ideal for peptide research laboratories and academic institutions

ARA-290 has been investigated in both preclinical and clinical research examining tissue protection, inflammation modulation, and peripheral nerve function. Published studies have explored its effects in models of:

• 
  Small fiber neuropathy
  
• 
  Diabetic neuropathy
  
• 
  Chronic inflammation
  
• 
  Tissue repair
  
• 
  Wound healing
  
• 
  Organ protection
  
• 
  Metabolic dysfunction
  

Study Designs

Published research has included:

• 
  Cell culture (in vitro) studies
  
• 
  Animal (preclinical) models
  
• 
  Randomized, placebo-controlled clinical trials
  
• 
  Mechanistic studies investigating innate repair receptor (IRR) signalling
  

Research Objectives

Studies have evaluated endpoints such as:

• 
  Changes in inflammatory biomarkers
  
• 
  Nerve fibre structure and function
  
• 
  Pain-related outcome measures
  
• 
  Tissue recovery following injury
  
• 
  Endothelial function
  
• 
  Cellular repair signalling
  

Mechanism Under Investigation

ARA-290 is designed to selectively activate the innate repair receptor (IRR), a receptor complex implicated in tissue-protective and anti-inflammatory signalling pathways. Unlike erythropoietin, it has been studied for these repair-related mechanisms without stimulating red blood cell production.

Research Status

ARA-290 remains an investigational peptide. Research is ongoing to better understand its biological activity, potential therapeutic applications, and long-term safety profile.

This format aligns well with a research-focused product page while avoiding human dosage instructions. It also matches the compliance-focused structure you've been using across your Health-Tech catalogue.

1. What is ARA-290?

ARA-290 is a synthetic peptide derived from erythropoietin (EPO) that has been investigated in scientific research for its potential role in tissue protection, inflammation modulation, and nerve repair mechanisms.

2. What is ARA-290 being researched for?

Published studies have explored ARA-290 in areas including:

• 
  Peripheral neuropathy
  
• 
  Small fiber neuropathy
  
• 
  Diabetic neuropathy
  
• 
  Chronic inflammation
  
• 
  Tissue repair
  
• 
  Wound healing
  
• 
  Organ protection
  
• 
  Metabolic disorders
  

3. How does ARA-290 differ from erythropoietin (EPO)?

Unlike erythropoietin, ARA-290 has been designed to selectively activate the innate repair receptor (IRR) without stimulating red blood cell production, making it useful for investigating tissue repair pathways independently of hematopoietic effects.

4. Is ARA-290 a growth hormone?

No. ARA-290 is not a growth hormone and does not belong to the GH or IGF-1 family. It is an erythropoietin-derived peptide.

5. What receptor does ARA-290 target?

Research suggests ARA-290 selectively binds to the innate repair receptor (IRR), which is associated with cellular protection and repair signalling.

6. Why is ARA-290 popular in neuropathy research?

Several published studies have investigated ARA-290 because of its potential effects on nerve function, inflammation, and tissue recovery, particularly in models of small fiber neuropathy and diabetic neuropathy.

7. Is ARA-290 suitable for laboratory research?

Yes. Health-Tech supplies ARA-290 exclusively for scientific and laboratory research applications.

8. How should ARA-290 be stored?

Storage should follow established laboratory protocols appropriate for peptide materials to help maintain stability and integrity.

9. What quality standards are used?

Health-Tech sources research peptides manufactured under stringent quality control procedures to promote batch consistency, purity, and reliable research performance.

10. Can ARA-290 be combined with other research peptides?

Researchers may investigate ARA-290 alongside other peptides depending on their study design. Compatibility and methodology should always be determined according to the objectives of the research protocol.

11. Does Health-Tech verify product quality?

Health-Tech partners with manufacturers that employ rigorous production and quality assurance processes to support high-quality research materials.

12. Is ARA-290 intended for human or veterinary use?

No. This product is supplied exclusively for scientific, laboratory, and analytical research purposes.

13. What makes ARA-290 different from other research peptides?

ARA-290 has attracted scientific interest because of its selective interaction with the innate repair receptor, allowing researchers to investigate tissue-protective pathways without the erythropoietic activity associated with erythropoietin.

14. Is there published research on ARA-290?

Yes. A growing body of peer-reviewed research has explored ARA-290 in areas including neuropathy, inflammation, metabolic disorders, wound healing, and tissue repair.

15. Where can I learn more about ARA-290 research?

Health-Tech regularly publishes educational articles summarizing peer-reviewed scientific literature on ARA-290 and other research peptides. Researchers are also encouraged to consult published journals and academic databases for the latest findings.

Current published research has investigated ARA-290 in relation to:

• 
  Peripheral neuropathy
  
• 
  Small fiber neuropathy
  
• 
  Diabetic neuropathy
  
• 
  Chronic inflammation
  
• 
  Tissue repair mechanisms
  
• 
  Wound healing research
  
• 
  Endothelial function
  
• 
  Autoimmune disease research
  
• 
  Mitochondrial health
  
• 
  Organ protection studies
  
• 
  Pain signalling pathways
  
• 
  Metabolic disease research